Acetoacetate protects neuronal cells from oxidative glutamate toxicity

Journal of Neuroscience Research

Volumn 83, Issue 4, 2006, Pages 702-709

  Noh, Hae Sook ^a   Hah, Young Sool ^a   Nilufar, Rashidova ^a   Han, Jaehee ^a   Bong, Jae Hwan ^a   Kang, Sang Soo ^a   Cho, Gyeong Jae ^a   Choi, Wan Sung ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

hydroxybutyrate; Acetoacetate; Glutamate; HT22; Ketogenic diet

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; GLUTAMIC ACID; LIPOCORTIN 5; LITHIUM ACETATE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; HIPPOCAMPUS; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACETOACETATES; ANIMALS; ANNEXIN A5; APOPTOSIS; CALCIUM; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; KETONE BODIES; MICE; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, GLUTAMATE;

EID: 33644889356     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20736     Document Type: Article

References (29)

1. Abdelmegeed MA, Kim SK, Woodcroft KJ, Novak RF. 2004. Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J Pharmacol Exp Ther 310:728-736.
2. Casazza JP, Felver ME, Veech RL. 1984. The metabolism of acetone in rat. J Biol Chem 59:231-236.
3. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
4. Garcia O, Massieu L. 2003. Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production. J Neurosci Res. 74:956-966.
5. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. 2000. D-β-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 97:5440-5444.
6. Laffel L. 1999. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15:412-426.
7. Likhodii SS, Burnham WM. 2002. Ketogenic diet: does acetone stop seizures? Med Sci Monit 8:HY19-HY24.
8. Maher P, Davis JB. 1996. The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 16:6394-6401.
9. Marie C, Bralet AM, Gueldry S, Bralet J. 1990. Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis. Metab Brain Dis 5:65-75.
10. Massieu L, Haces ML, Montiel T, Hernandez-Fonseca K. 2003. Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 120:365-378.
11. Morimoto BH, Koshland DE Jr. 1990. Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line. Neuron 5:875-880.
12. Masuda R, Monahan JW, Kashiwaya Y. 2005. D-β-hydroxybutyrate is neuroprotective against hypoxia in serum-free hippocampal primary cultures. J Neurosci Res 80:501-509.
13. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT. 1989. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558.
14. Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, Cho GJ, Choi WS. 2003. The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 53:119-128.
15. Nordli DR Jr, Koenigsberger D, Schroeder J, DeVivo DC. 1992. Ketogenic diets. In: Resor SR Jr, editor. The medical treatment of epilepsy. New York: Marcel Dekker. p 455-471.
16. 31P spectroscopic imaging at 4.1 T. Epilepsia 40:703-707.
17. Patel M. 2004. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Rad Biol Med 37:1951-1962.
18. 2+ homeostasis. Neurosci Res 37:227-236.
19. Rho JM, Anderson GD, Donevan SD, White HS. 2002. Acetoacetate, acetone, and dibenzylamine (a contaminant in 1-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43: 358-361.
20. Schubert D, Piasecki D. 2001. Oxidative glutamate toxicity can be a component of the excitotoxicity cascade. J Neurosci 21:7455-7462.
21. Schubert D, Kimura H, Maher P. 1992. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci U S A 89:8264-82647.
22. Sewell JM, Mayer SP, Langdon JF, Smyth DI, Jodrell SM, Guichard SM. 2005. The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell lines. Eur J Cancer 41:1637-1644.
23. Sokoloff L. 1973. Metabolism of ketone bodies by the brain. Annu Rev Med 24:271-280.
24. Sudha K, Rao AV, Rao A. 2001. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 303:19-24.
25. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. 2004. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 55:576-580.
26. Suzuki M, Suzuki M, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A. 2001. Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol 87:143-150.
27. Tan S, Sagara Y, Liu Y, Maher P, Schubert D. 1998. The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 141:1423-1432.
28. Thio LL, Wong M, Yamada KA. 2000. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54:325-331.
29. Ziegler DR, Ribeiro LC, Hagenn M, Siqueira IR, Araujo E, Torres IL, Gottfried C, Netto CA, Goncalves CA. 2003. Ketogenic diet increases glutathione peroxidase activity in rat hippocampus. Neurochem Res 28:1793-1797.